Literature DB >> 6828267

Chronic anovulation syndrome and associated neoplasia.

C B Coulam, J F Annegers, J S Kranz.   

Abstract

Ovarian hormones have been implicated in a number of neoplastic conditions. Chronic anovulation syndrome, a spontaneous biologic experiment of unopposed secretion of estrogen by the ovaries, was identified in a cohort of 1270 patients, and the risk of these patients having neoplasia was studied. Of the 1270 patients studied, 30 had a subsequent malignancy develop; the expected number was 29.8. When the individual types of subsequent malignancy were analyzed, the endometrium was the only site at increased risk. The relative risk of developing carcinoma of the endometrium after the diagnosis of chronic anovulation syndrome is 3.1 (95% confidence interval 1.1 to 7.3). The long-term risk of developing adenocarcinoma of the endometrium might be considered when treating patients who have this syndrome.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6828267

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  29 in total

Review 1.  Overtraining in athletes. An update.

Authors:  R W Fry; A R Morton; D Keast
Journal:  Sports Med       Date:  1991-07       Impact factor: 11.136

2.  Polycystic Ovary Syndrome, Oligomenorrhea, and Risk of Ovarian Cancer Histotypes: Evidence from the Ovarian Cancer Association Consortium.

Authors:  Holly R Harris; Ana Babic; Penelope M Webb; Christina M Nagle; Susan J Jordan; Harvey A Risch; Mary Anne Rossing; Jennifer A Doherty; Marc T Goodman; Francesmary Modugno; Roberta B Ness; Kirsten B Moysich; Susanne K Kjær; Estrid Høgdall; Allan Jensen; Joellen M Schildkraut; Andrew Berchuck; Daniel W Cramer; Elisa V Bandera; Nicolas Wentzensen; Joanne Kotsopoulos; Steven A Narod; Catherine M Phelan; John R McLaughlin; Hoda Anton-Culver; Argyrios Ziogas; Celeste L Pearce; Anna H Wu; Kathryn L Terry
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-11-15       Impact factor: 4.254

Review 3.  Clinical consequences of athletic amenorrhoea.

Authors:  N W Constantini
Journal:  Sports Med       Date:  1994-04       Impact factor: 11.136

4.  Prevalence of Polycystic Ovary Syndrome Phenotypes Using Updated Criteria for Polycystic Ovarian Morphology: An Assessment of Over 100 Consecutive Women Self-reporting Features of Polycystic Ovary Syndrome.

Authors:  Nina M Clark; Amanda J Podolski; Eric D Brooks; Donna R Chizen; Roger A Pierson; Denis C Lehotay; Marla E Lujan
Journal:  Reprod Sci       Date:  2014-02-11       Impact factor: 3.060

5.  Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study.

Authors:  H R Harris; L J Titus; D W Cramer; K L Terry
Journal:  Int J Cancer       Date:  2016-10-06       Impact factor: 7.396

Review 6.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

7.  Comparison of clinical features and health manifestations in lean vs. obese Indian women with polycystic ovarian syndrome.

Authors:  Abha Majumdar; Tejshree A Singh
Journal:  J Hum Reprod Sci       Date:  2009-01

8.  Cancer risk among infertile women with androgen excess or menstrual disorders (including polycystic ovary syndrome).

Authors:  Louise A Brinton; Kamran S Moghissi; Carolyn L Westhoff; Emmet J Lamb; Bert Scoccia
Journal:  Fertil Steril       Date:  2009-11-25       Impact factor: 7.329

9.  [Dysfunctional bleeding and dyshormonal disorders of bleeding].

Authors:  J Hammerstein
Journal:  Arch Gynecol Obstet       Date:  1987       Impact factor: 2.344

10.  Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women's Health Study.

Authors:  T A Sellers; J D Potter; R K Severson; R M Bostick; C L Nelson; L H Kushi; A R Folsom
Journal:  Cancer Causes Control       Date:  1993-01       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.